Back

Adverse effect of left ventricular hypertrophy in women with heart failure

28 August 2026 (08:15 - 08:45)
Organised by: Logo
Congress Presentation Part of: Predicting prognosis in heart failure Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Alon Kaplan

Sheba Medical Center, Ramat Gan (Israel)

4 More presentations in this session

Presentation thumbnail
Prognostic significance of cardiopulmonary exercise testing parameters for predicting all-cause mortality in chronic heart failure patients: a cohort study
Doctor P. Iliakis (Athens, GR)
Abstract Slides
Presentation thumbnail
Prognostic value of symptom-limited cardiopulmonary exercise testing outcomes on composite clinical outcomes and echocardiographic remodeling in patients with heart failure: a prospective cohort study
Miss C. Wang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Subsequent pregnancy in women with prior peripartum cardiomyopathy: the prognostic role of baseline LVEF
Doctor N. Shamsieva (Tashkent, UZ)
Abstract Slides
Presentation thumbnail
Prognostic impact of prolonged QRS duration on cardiovascular outcomes in chronic heart failure without ventricular pacing or cardiac resynchronization therapy: a systematic review and meta-analysis
Doctor G. Caldeira Gaelzer (Curitiba, BR)
Abstract Slides

Access the full session

Session thumbnail
Predicting prognosis in heart failure

The Event

Event poster

ESC Congress 2026

28 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Do we need lower cut-offs of left ventricular wall thickness to suspect cardiac amyloidosis in women?
22 May 2023
thumbnail
Congress Presentation
Prognostic implication of LV dysfunction detected by global longitudinal strain and left ventricular hypertrophy in patients with hypertension
23 May 2023
thumbnail
Congress Presentation
Sex-based differences in heart failure development after STEMI
21 March 2026
thumbnail
Congress Presentation
Effect of different phenotypes of hypertrophic cardiomyopathy on clinical outcomes
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources